Skip to main content
TrimSoMoEverything GLP-1, in one place
Important FDA Methodological & Epidemiological Notice:

FAERS reports are voluntary, post-marketing submissions from healthcare providers, patients, and manufacturers. FAERS reports do not prove that a drug caused an event, and they cannot be used to estimate how often an event happens.

Illustration of a staircase of small soft blocks
FDA labels & FAERS public data

GLP-1 Side Effects:
What the FDA labels list

FAERS collects voluntary reports of adverse events. A report does not prove that a medication caused the event, and report counts cannot be used to estimate how often an event happens.

Side effects listed in FDA labels

Each item below appears in the FDA-approved prescribing information linked beside it (labels checked November 4, 2026). This list is not complete; read the full label and talk to your prescriber.

Both labels include a boxed warning for thyroid C-cell tumors. Suspected side effects can be reported to the FDA through MedWatch. Published FAERS data are available on the FAERS public dashboard; FAERS reports do not prove that a drug caused an event.

Clinician Support

Need personalized clinician support for dose adjustments?

Your prescribing clinician manages dose changes. Telehealth programs differ in follow-up and messaging; confirm services and terms with each program.